BRPI0516244A - derivados de benzodiazepina substituìda por halogênio - Google Patents

derivados de benzodiazepina substituìda por halogênio

Info

Publication number
BRPI0516244A
BRPI0516244A BRPI0516244-0A BRPI0516244A BRPI0516244A BR PI0516244 A BRPI0516244 A BR PI0516244A BR PI0516244 A BRPI0516244 A BR PI0516244A BR PI0516244 A BRPI0516244 A BR PI0516244A
Authority
BR
Brazil
Prior art keywords
halogen substituted
benzodiazepine derivatives
substituted benzodiazepine
halogen
derivatives
Prior art date
Application number
BRPI0516244-0A
Other languages
English (en)
Inventor
Henner Knust
Andrew Willian Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35735152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0516244(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0516244A publication Critical patent/BRPI0516244A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DE BENZODIAZEPINA SUBSTITUìDA POR HALOGêNIO. A invenção refere-se a derivados de imidazo¢1,5-a!¢1, 2, 5 4!triazol¢1,5-d!¢1,4!benzodiazepina substituído por halogênio de fórmula e a seus sais de adição ácidos farmaceuticamente aceitáveis. Os compostos podem ser usados para o tratamento de realçador cognitivo, distúrbios cognitivos, ansiedade, doença de Alzheimer e esquizofrenia.
BRPI0516244-0A 2004-10-20 2005-10-11 derivados de benzodiazepina substituìda por halogênio BRPI0516244A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105167 2004-10-20
PCT/EP2005/010907 WO2006045429A1 (en) 2004-10-20 2005-10-11 Halogen substituted benzodiazepine derivatives

Publications (1)

Publication Number Publication Date
BRPI0516244A true BRPI0516244A (pt) 2008-08-26

Family

ID=35735152

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516244-0A BRPI0516244A (pt) 2004-10-20 2005-10-11 derivados de benzodiazepina substituìda por halogênio

Country Status (17)

Country Link
US (1) US7507728B2 (pt)
EP (1) EP1807432A1 (pt)
JP (1) JP4751398B2 (pt)
KR (1) KR100915469B1 (pt)
CN (1) CN101084220B (pt)
AR (1) AR051333A1 (pt)
AU (1) AU2005299031B2 (pt)
BR (1) BRPI0516244A (pt)
CA (1) CA2584757C (pt)
IL (1) IL182697A (pt)
MX (1) MX2007004640A (pt)
NO (1) NO20072046L (pt)
NZ (1) NZ554556A (pt)
RU (1) RU2007114763A (pt)
TW (1) TWI304404B (pt)
WO (1) WO2006045429A1 (pt)
ZA (1) ZA200703244B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0617204A2 (pt) * 2005-10-11 2011-07-19 Hoffmann La Roche derivados de imidazo benzodiazepina
EP2457569A1 (en) 2010-11-05 2012-05-30 F. Hoffmann-La Roche AG Use of active pharmaceutical compounds for the treatment of central nervous system conditions
MX341471B (es) 2010-11-05 2016-08-22 Hoffmann La Roche Uso de compuestos farmaceuticos activos para el tratamiento de estados patologicos del sistema nervioso central.
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
NZ760341A (en) * 2013-12-20 2021-12-24 Agenebio Inc Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MX392119B (es) 2015-06-19 2025-03-11 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar deterioro cognitivo
US11505555B2 (en) 2016-12-19 2022-11-22 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
SG11202001240XA (en) * 2017-09-07 2020-03-30 Eisai R&D Man Co Ltd Pentacyclic compound
CN112601749B (zh) 2018-06-19 2024-03-26 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂环庚三烯衍生物，组合物和方法
EA202191966A1 (ru) 2019-03-05 2021-12-08 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Пентациклическое гетероциклическое соединение
BR112021015979A2 (pt) 2019-03-05 2021-10-05 Eisai R&D Management Co., Ltd. Sal de composto pentacíclico e cristal do mesmo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL49161A (en) * 1975-08-07 1982-04-30 Sparamedica Ag Imidazo(1,5-a)(1,4)-diazepine derivatives,their manufacture and pharmaceutical compositions containing them
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
IL74070A (en) 1984-01-19 1988-12-30 Hoffmann La Roche Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
US4897392A (en) * 1989-07-03 1990-01-30 Hoechst-Roussel Pharmaceuticals, Inc. 4H-indolo(1,2-d)(1,2,4)triazolo(4,3-A)(1,4)benzodiazepines
TW201311B (pt) * 1991-06-17 1993-03-01 Hoffmann La Roche
JPH078869A (ja) * 1993-06-29 1995-01-13 Mitsubishi Chem Corp 粉粒体のコーティング方法
TWI239333B (en) * 2000-11-16 2005-09-11 Hoffmann La Roche Benzodiazepine derivatives as GABA A receptor modulators
US6686352B2 (en) * 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives

Also Published As

Publication number Publication date
MX2007004640A (es) 2007-06-08
AR051333A1 (es) 2007-01-03
CA2584757C (en) 2012-07-03
AU2005299031B2 (en) 2011-11-10
IL182697A0 (en) 2007-09-20
CN101084220B (zh) 2010-12-15
WO2006045429A1 (en) 2006-05-04
KR100915469B1 (ko) 2009-09-03
NZ554556A (en) 2009-11-27
NO20072046L (no) 2007-04-26
CA2584757A1 (en) 2006-05-04
US7507728B2 (en) 2009-03-24
JP4751398B2 (ja) 2011-08-17
ZA200703244B (en) 2008-08-27
KR20070085398A (ko) 2007-08-27
IL182697A (en) 2012-02-29
AU2005299031A1 (en) 2006-05-04
TWI304404B (en) 2008-12-21
CN101084220A (zh) 2007-12-05
JP2008517010A (ja) 2008-05-22
US20060084801A1 (en) 2006-04-20
EP1807432A1 (en) 2007-07-18
TW200630371A (en) 2006-09-01
RU2007114763A (ru) 2008-11-27

Similar Documents

Publication Publication Date Title
NO20072046L (no) Halogensubstituerte benzodiazepinderivater
NO20071967L (no) Imidazo-benzodiazepinderivater
GEP20125405B (en) Amino-heterocyclic compounds
CN107635999B (zh) 用于治疗脊髓性肌萎缩的化合物
MX2010001677A (es) Derivados de 4-(9-(3,3-difluorociclopentil)-5,7,7-trimetil-6-oxo-6 ,7,8,9-tetrahidro-5h-pirimido[4,5-b][1,4]diazepin-2-ilamino)-3-me toxibenzamida como inhibidores de las proteinas cinasas humanas plk1 a plk4 para el tratamiento de enfermedades proli
MA29437B1 (fr) Compose d'imidazopyridazine
MA27734A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]PYRIMIDINE-4,7-DIONE SUBSTITUES SUR L'AZOTE, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
MY138352A (en) Benzothiazole derivatives
JP2010516812A (ja) 有糸分裂キナーゼの調節剤
DE602005016718D1 (de) Ä1,2,4ütriazoloä4,3-aüpyridin-derivative zur behandlung hyperproliferativer erkrankungen
CY1111921T1 (el) 7-[2-[4-(6-ΦΘΟΡΟ-3-ΜΕΘΥΛ-1,2-ΒΕΝΖΙΣΟΞΑΖΟΛ-5-ΥΛ)-1-ΠΙΠΕΡΑΖΙΝΥΛ]ΑΙΘΥΛ]-2-(1-ΠΡΟΠΥΝΥΛ)-7Η-ΠΥΡΑΖΟΛΟ-[4,3-e]-[1,2,4]-ΤΡΙΑΖΟΛΟ[1,5-c]ΠΥΡΙΜΙΔΙΝ-5-ΑΜΙΝΗ
MA27654A1 (fr) DERIVES HEXAHYDROPYRAZINO [1,2-a]-4,7-DIONE SUBSTITUES, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS
IL190398A0 (en) Imidazo benzodiazepine derivatives
NO20055510L (no) 2-alkynyl- og 2-alkenylpyrazolo [4,3-E]-1,2,4-triazolo-[1,5-C]-pyrimidin-adenosin A2A-reseptorantagonister
JP7319369B2 (ja) ヘテロ芳香族ｎｍｄａ受容体モジュレーターおよびその使用
ATE402707T1 (de) Imidazoä1,5aütriazoloä1,5dübenzodiazepin- derivative zur behandlung kognitiver störungen
MXPA05013628A (es) Pirazolo[3,4-b]piridin-6-onas como inhibidores de gsk-3.
JP2002205957A (ja) 鬱病、不安症及び精神病のための組み合せ治療
TW200631953A (en) Tetracyclic imidazo-benzodiazepines
RU2393157C1 (ru) 2-АЛКИЛАМИНО-3-АРИЛСУЛЬФОНИЛ-ПИРАЗОЛО[1,5-а]ПИРИМИДИНЫ, АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
ZA200609337B (en) Use of opioid antagonist compounds for the prevention and/or treatment of diseases associated with the target calcineurin
IL184439A0 (en) 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1
MXPA06000193A (es) Derivados de imidazol iii.
WO2005007630A3 (en) Aryl fused azapolycyclic compounds
TH79587A (th) อนุพันธ์ของอิมิดาโซ-เบนโซไดอะซีพีน

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.